date,title,source
Oct-31-18,MNOV: MN-166 to be Studied in Degenerative Cervical Myelopathy,Zacks Small Cap Research
Dec-12-18,"Do Insiders Own Lots Of Shares In MediciNova, Inc. (NASDAQ:MNOV)?",Simply Wall St.
Dec-12-18,MediciNova to Present at the J.P. Morgan Healthcare Conference in San Francisco,GlobeNewswire
Jan-07-19,MediciNova Receives Notice of Allowance for New Patent Covering MN-001 and MN-002 for the Treatment of Fibrosis in Japan,GlobeNewswire
Jan-08-19,MediciNova Announces Initiation of Enrollment in a Clinical Trial of MN-166 (ibudilast) in Glioblastoma,GlobeNewswire
Jan-09-19,"The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study",Benzinga
Feb-12-19,"One Thing To Remember About The MediciNova, Inc. (NASDAQ:MNOV) Share Price",Simply Wall St.
Feb-20-19,MNOV: Continuing to Plan for Phase 3 Studies in Progressive MS and ALS,Zacks Small Cap Research
Feb-28-19,MediciNova Announces the Publication of Results of the Animal Model Study of MN166 (ibudilast) in Glioblastoma in Scientific Reports,GlobeNewswire
Mar-05-19,"MediciNova Announces MN-001 Research Collaboration with The Jikei University School of Medicine in Tokyo, Japan",GlobeNewswire
Apr-01-19,MediciNova Announces Results of Subgroup Analysis from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS,GlobeNewswire
Apr-03-19,"MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in China",GlobeNewswire
